Clinical Trial

Automated Insulin for Management of Intrapartum Glycemia

Study acronym: AIMING
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is learn if automated insulin delivery (AID) systems can be used for glucose management during labor/delivery for pregnant people with type 1 diabetes (T1D). The main questions this study aims to answer are * What are the neonatal glycemic outcomes with use of AID systems during labor/delivery? * Do patients report higher birth satisfaction with use of AID systems during labor/delivery? * Are glycemic parameters like time-in-range (TIR) better with use of AID systems during labor/delivery? Researchers will compare AID systems to intravenous (IV) insulin (the current standard of care for glucose management during labor/delivery) by randomly assigning participants to one or the other.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-12-31 -> 2028-12-31 2026-05-19
minor Completion pushed: 2026-12-31 -> 2028-12-31 2026-05-19
Trial Details
NCT Number NCT06883344
Lead Sponsor University of California, San Francisco
Conditions Type 1 Diabetes (T1D), Pregnancy, Pre-Gestational Diabetes
Enrollment 150 participants
Start Date 2025-12-05
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-13